Deversify Health AB (OSTO:DEV) ROCE % : -422.49% (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Deversify Health AB ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Deversify Health AB's annualized ROCE % for the quarter that ended in Jun. 2024 was -422.49%.

Deversify Health AB ROCE % Historical Data

The historical data trend for Deversify Health AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deversify Health AB ROCE % Chart

Deversify Health AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

-27.38

79.97

-70.75

-77.53

-134.52

Deversify Health AB Quarterly Data
	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23	Mar24	Jun24
ROCE %	Get a 7-Day Free Trial										-3.57	-63.15	-	-112.06	-422.49

Deversify Health AB ROCE % Calculation

Deversify Health AB's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-21.008	/	( ( (36.37 - 12.606)	+	(15.827 - 8.357) )	/ 2 )
	=	-21.008	/	( (23.764	+	7.47)	/ 2 )
	=	-21.008	/	15.617
	=	-134.52 %

Deversify Health AB's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Mar. 2024 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Mar. 2024 )		(Q: Jun. 2024 )
	=	-4.508	/	( ( (13.683 - 8.317)	+	(0.616 - 3.848) )	/ 2 )
	=	-4.508	/	( ( 5.366	+	-3.232 )	/ 2 )
	=	-4.508	/	1.067
	=	-422.49 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2024) EBIT data.

Deversify Health AB (OSTO:DEV) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Deversify Health AB ROCE % Related Terms

Thank you for viewing the detailed overview of Deversify Health AB's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Deversify Health AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » Deversify Health AB (OSTO:DEV) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ulls vag 29C, Uppsala, SWE, 756 51

Website

https://www.deversify.com

Deversify Health AB offers health tech solutions for consumers. The company develops and commercializes mobile electronic devices and apps to monitor biomarkers for individualized health, specializing in breathalyzers. The company also develops and provides education services regarding metabolic health and personalized nutrition.